A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/12 (2006.01) A61K 9/14 (2006.01) A61K 9/19 (2006.01) A61K 9/72 (2006.01) A61K 47/18 (2006.01)
Patent
CA 2389219
The present invention provides a highly dispersible formulation comprising an active agent and a dipeptide or tripeptide comprising at least two leucyl residues. The composition of the invention possesses superior aerosol properties and is thus preferred for aerosolized administration to the lung. Also provided are a method for (i) increasing the dispersibility of an active-agent containing formulation for administration to the lung, and (ii) delivery of the composition to the lungs of a subject.
La présente invention concerne une formulation hautement dispersable contenant un agent actif et un dipeptide ou un tripeptide comprenant au moins deux résidus leucyl. La composition de l'invention présente des propriétés aérosol supérieures et par conséquent on la préconise pour une administration en aérosol dans les poumons. En outre, cette invention concerne un procédé pour: (a) augmenter la dispersabilité d'une formulation contenant un agent actif pour l'administrer aux poumons, et (b) administrer la composition aux poumons du sujet.
Kuo Mei-Chang
Lechuga-Ballesteros David
Gowling Lafleur Henderson Llp
Inhale Therapeutic Systems Inc.
Novartis Ag
LandOfFree
Dry powder compositions having improved dispersivity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dry powder compositions having improved dispersivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dry powder compositions having improved dispersivity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1648509